Natalia Vazquez-Mena

Malaga, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Window of opportunity with abatacept in Rheumatoid arthritis-associated interstitial lung disease: A multicentre study of 526 patients.

Window of opportunity with abatacept in Rheumatoid arthritis-associated interstitial lung disease: A multicentre study of 526 patients.

Journal: European journal of internal medicine

Published: April 01, 2026

The economic burden of moderate-to-severe rheumatoid arthritis in Spain: the CIARA study.

The economic burden of moderate-to-severe rheumatoid arthritis in Spain: the CIARA study.

Journal: Journal of medical economics

Published: March 31, 2026

Validation of screening criteria for interstitial lung disease in rheumatoid arthritis in routine clinical practice: the VAR-EPIDSER study.

Validation of screening criteria for interstitial lung disease in rheumatoid arthritis in routine clinical practice: the VAR-EPIDSER study.

Journal: RMD open

Published: March 10, 2026

Plasma miR-134-5p: a candidate biomarker for predicting non-response to anti-TNF therapy in rheumatoid arthritis.

Plasma miR-134-5p: a candidate biomarker for predicting non-response to anti-TNF therapy in rheumatoid arthritis.

Journal: Frontiers in immunology

Published: January 07, 2026

Association between intestinal permeability, systemic inflammation, and response to anti-TNF therapy in patients with rheumatoid arthritis: a prospective controlled study.

Association between intestinal permeability, systemic inflammation, and response to anti-TNF therapy in patients with rheumatoid arthritis: a prospective controlled study.

Journal: Frontiers in immunology

Published: November 28, 2025

Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicentre cohort of 526 patients.

Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicentre cohort of 526 patients.

Journal: Rheumatology (Oxford, England)

Published: August 26, 2025

Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortality.

Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortality.

Journal: Lupus science & medicine

Published: August 06, 2025

Longitudinal Assessment of Body Composition and Inflammatory Status in Rheumatoid Arthritis During TNF Inhibitor Treatment: A Pilot Study.

Longitudinal Assessment of Body Composition and Inflammatory Status in Rheumatoid Arthritis During TNF Inhibitor Treatment: A Pilot Study.

Journal: International journal of molecular sciences

Published: July 07, 2025

Analysis of epigenetic biomarkers for diagnosis and assessment of severity in rheumatoid arthritis: a cross-sectional study.

Analysis of epigenetic biomarkers for diagnosis and assessment of severity in rheumatoid arthritis: a cross-sectional study.

Journal: Arthritis research & therapy

Published: April 18, 2025

Real-world use of nintedanib for the treatment of interstitial lung disease with progressive pulmonary fibrosis.

Real-world use of nintedanib for the treatment of interstitial lung disease with progressive pulmonary fibrosis.

Journal: Medicina clinica

Published: April 01, 2025

Identifying inflammatory phenotypes associated with lung involvement in systemic sclerosis: k-means clustering approach.

Identifying inflammatory phenotypes associated with lung involvement in systemic sclerosis: k-means clustering approach.

Journal: Frontiers in immunology

Published: January 30, 2025

Baricitinib in rheumatoid arthritis-interstitial lung disease: a literature review and national multicentre study of 72 patients.

Baricitinib in rheumatoid arthritis-interstitial lung disease: a literature review and national multicentre study of 72 patients.

Journal: Rheumatology (Oxford, England)

Published: January 22, 2025

Showing 1-12 of 86

Last Updated: 09/26/2026